The development of artificial intelligence (AI) is paving the way for proactive medicine, focused on preventing diseases, rather than just treating them. This was stated by the head of Sberbank, German Gref, at the "National Healthcare — 2025" congress.
Gref noted that demographic changes and increased life expectancy pose a challenge to medicine not only to extend life, but also to improve its quality. This requires a transition from reactive healthcare to a predictive model, where AI and digital data help in the early detection of pathologies and monitoring of health status.
Today, artificial intelligence is becoming a key driver in the development of all sciences, especially medicine. Our GigaChat development meets international standards and has already shown a 30% reduction in diagnostic errors.
According to him, even at an early stage of implementation, AI demonstrates high diagnostic accuracy and successful accreditation in various medical fields.
Gref called the creation of an ecosystem of interacting AI agents, Agent Verse AGI-Med, a promising direction. In such a system, some agents help doctors, others help patients, and still others coordinate the work of institutions. This distributed interaction increases the autonomy of medicine, reduces the burden on staff, and speeds up service.
